ICAD

ICAD EBITDA Growth YoY

Delisted

The Year-over-Year EBITDA Growth of ICAD (ICAD) as of Nov 6, 2026 is 19.01 %. In the previous year, Year-over-Year EBITDA Growth was 45.73 % — a change of -58.44% (lower).

EBITDA Growth YoY

19.01 %

YoY

-58.44%

Last updated:

Year-over-Year EBITDA Growth of ICAD is 2024 19.01 % . Year-over-Year EBITDA Growth of ICAD was 2023 45.73 % . It decreases by -58.44% lower compared to the previous year.

The ICAD EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2017
-54.80 USD
Jan 1, 2018
42.92 USD
Jan 1, 2019
21.78 USD
Jan 1, 2020
-50.20 USD
Jan 1, 2021
-18.23 USD
Jan 1, 2022
-26.21 USD
Jan 1, 2023
45.73 USD
Jan 1, 2024
19.01 USD
The ICAD EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
19.01 %-58.44%
45.73 %-274.50%
-26.21 %+43.76%
-18.23 %-63.69%
-50.20 %-330.53%
21.78 %-49.26%
42.92 %-178.32%
-54.80 %-179.55%
68.89 %-105.68%
-1,213.46 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ICAD Stock analysis

What does ICAD do? ICAD Inc is a leading company in medical imaging and automated image processing. It was founded in 1984 and is headquartered in Nashua, New Hampshire, USA. ICAD is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ICAD stock

Year-over-Year EBITDA Growth of ICAD is 19.01 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth ICAD since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's ICAD historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — ICAD

All Key Metrics — ICAD